Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10004783HBVENSG00000116329.12protein_codingOPRD1NoNo4985P41143
TVIS30074531HIVENSG00000116329.12protein_codingOPRD1NoNo4985P41143
TVIS30022908HIVENSG00000116329.12protein_codingOPRD1NoNo4985P41143
TCGA Plot Options
Drug Information
GeneOPRD1
DrugBank IDDB01439
Drug Name3-Methylthiofentanyl
Target IDBE0000420
UniProt IDP41143
Regulation Typeagonist
PubMed IDs15665994; 15828941; 15868528; 16372825; 16861092; 19403616
CitationsRodrigues AR, Castro MS, Francischi JN, Perez AC, Duarte ID: Participation of ATP-sensitive K+ channels in the peripheral antinociceptive effect of fentanyl in rats. Braz J Med Biol Res. 2005 Jan;38(1):91-7. Epub 2005 Jan 18.@@Poonawala T, Levay-Young BK, Hebbel RP, Gupta K: Opioids heal ischemic wounds in the rat. Wound Repair Regen. 2005 Mar-Apr;13(2):165-74.@@Sahin AS, Duman A, Atalik EK, Ogun CO, Sahin TK, Erol A, Ozergin U: The mechanisms of the direct vascular effects of fentanyl on isolated human saphenous veins in vitro. J Cardiothorac Vasc Anesth. 2005 Apr;19(2):197-200.@@Darwish M, Tempero K, Kirby M, Thompson J: Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers. Clin Pharmacokinet. 2005;44(12):1279-86.@@Darwish M, Kirby M, Robertson P Jr, Tracewell W, Jiang JG: Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers. Clin Ther. 2006 May;28(5):707-14.@@Hajiha M, DuBord MA, Liu H, Horner RL: Opioid receptor mechanisms at the hypoglossal motor pool and effects on tongue muscle activity in vivo. J Physiol. 2009 Jun 1;587(Pt 11):2677-92. doi: 10.1113/jphysiol.2009.171678. Epub 2009 Apr 29.
GroupsExperimental; Illicit
Direct ClassificationAnilides
SMILESCCC(=O)N(C1CCN(CCC2=CC=CS2)CC1C)C1=CC=CC=C1
Pathways3-Methylthiofentanyl Action Pathway
PharmGKB
ChEMBLCHEMBL2365680